OptimizeRx(OPRX) - 2024 Q2 - Quarterly Results

Exhibit 99.1 OptimizeRx Reports Second Quarter 2024 Financial Results - Q2 revenue of $18.8 million, increasing 36% year-over-year - Q2 gross profit increased 50% year-over-year to$ 11.7 million with a gross margin of 62% - Won 8 DAAP deals during Q2 WALTHAM, Mass. – August 8, 2024 – OptimizeRx Corp. (the "Company") (Nasdaq: OPRX), the leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and patients, reported results for the th ...